From professional translators, enterprises, web pages and freely available translation repositories.
mycodex high potency
mycodex high potency (product)
Last Update: 2014-12-09
Usage Frequency: 1
Quality:
Warning: This alignment may be wrong.
Please delete it you feel so.
mycodex high potency (producto)
mycodex high potency (product)
Last Update: 2014-12-09
Usage Frequency: 1
Quality:
Warning: This alignment may be wrong.
Please delete it you feel so.
the concept of a limiting reagent. 4.
the concept of a limiting reagent. 4.
Last Update: 2018-02-13
Usage Frequency: 1
Quality:
batch potency testing of immunological veterinary medicinal products
batch potency testing of immunological veterinary medicinal products
Last Update: 2011-10-23
Usage Frequency: 1
Quality:
Warning: This alignment may be wrong.
Please delete it you feel so.
reagent n es una prueba de diagnóstico rápido para determinar el recuento de células somáticas en la leche cruda.
reagent n is a product for quick tests of cell content in raw milk, detecting clinical and subclinical mastitis in each udder quarter.
Last Update: 2018-02-13
Usage Frequency: 1
Quality:
testing of residual moisture eu requirements for batches with maximum and minimum titre or batch potency for developmental safety and efficacy studies
testing of residual moisture
Last Update: 2011-10-23
Usage Frequency: 1
Quality:
Warning: This alignment may be wrong.
Please delete it you feel so.
diazepam is often recommended due to its long elimination half-life and also because of its availability in low potency doses.
diazepam is often recommended due to its long elimination half-life and also because of its availability in low potency doses.
Last Update: 2016-03-03
Usage Frequency: 1
Quality:
coload1 potency puede ser más allá realzado vía el uso de terapéutico transgenes, los cuales pueden ser introducidos al coload1 genoma sin compromising la selectividad o actividad del virus.
coload1 potency can be further enhanced via the use of therapeutic transgenes, which can be introduced into the coload1 genome without compromising the selectivity or activity of the virus.
Last Update: 2016-03-03
Usage Frequency: 1
Quality:
la necesidad para aumentado potency (infectivity y lytic actividad) ha dirigido a una búsqueda expandida que implica un número más grande de menos bien estudiado adenovirus serotypes.
the need for increased potency (infectivity and lytic activity) has led to an expanded search involving a larger number of less well studied adenovirus serotypes.
Last Update: 2016-03-03
Usage Frequency: 1
Quality:
título del documento requirements and controls applied to bovine serum used in the production of immunological veterinary medicinal products eu requirements for batches with maximum and minimum titre or batch potency for developmental safety and efficacy studies requirements for live recombinant vectored vaccines requirements for compatibility statements for veterinary vaccines harmonisation of requirements for potency and batch consistency of vaccines vich:
eu requirements for batches with maximum and minimum titre or batch potency for developmental safety and efficacy studies requirements for live recombinant vectored vaccines requirements for compatibility statements for veterinary vaccines harmonisation of requirements for potency and batch consistency of vaccines vich:
Last Update: 2011-10-23
Usage Frequency: 1
Quality:
Warning: This alignment may be wrong.
Please delete it you feel so.
título de la directriz definition of a new biological active substance in terms of active, passive immunity and immunomodulators which then constitute a new active ingredient batch potency testing of immunological veterinary medicinal products indications and specific c laims for veterinary vaccines dna vaccines non-a m p lifiab le in eukaryotic c e lls for veterinary use
title of guideline def inition of a new biological active substance in terms of active, passive immunity and immunomodulators which then constitute a new active ingredient batch potency testing of immunological veterinary medicinal products indications and specif ic claims for veterinary vaccines dna vaccines non-amplif iable in eukaryotic cells for veterinary use
Last Update: 2008-03-04
Usage Frequency: 1
Quality:
Warning: This alignment may be wrong.
Please delete it you feel so.
grupo de trabajo del cvmp " medicamentos inmunológicos veterinarios "título del documento requirements and controls applied to bovine serum used in the production of immunological veterinary medicinal products eu requirements for batches with maximum and minimum titre or batch potency for developmental safety and efficacy studies requirements for live recombinant vectored vaccines requirements for compatibility statements for veterinary vaccines harmonisation of requirements for potency and batch consistency of vaccines vich:
cvmp immunologicals working party document title requirements and controls applied to bovine serum used in the production of immunological veterinary medicinal products eu requirements for batches with maximum and minimum titre or batch potency for developmental safety and efficacy studies requirements for live recombinant vectored vaccines requirements for compatibility statements for veterinary vaccines harmonisation of requirements for potency and batch consistency of vaccines vich:
Last Update: 2008-03-04
Usage Frequency: 1
Quality:
Warning: Contains invisible HTML formatting
Warning: This alignment may be wrong.
Please delete it you feel so.